ClinicalTrials.gg
CompletedNCT06548646Updated Oct 16, 2026

Ultrasound-guided Thoracic Interfascial Plane Nerve Block Versus Erector Spinae Plane Block for Pain Control After Modified Radical Mastectomy

An interventional study of Thoracic Interfascial Plane Block and Erector Spinae Plane Block in Postoperative Pain Following Modified Radical Mastectomy for Breast Cancer, sponsored by Safie ramez tewfeik abd el moneim. Completed at 1 site in Egypt. Open to female participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Safie ramez tewfeik abd el moneim · Not applicable, Interventional, and Treatment

How we know

Updated Oct 16, 2026Now CompletedPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
21 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 248 studies in Breast Neoplasms with a site in Egypt — 58 open to participants now, 68 under way, 5 of them phase 3. Breast Neoplasms · Egypt.

Enrollment
27th of 183
200 · median 70
Started
2024
with 30 others
No phase
85 of 248
22 open now
Registered
180th of 248
by date

Among the 248 studies in Breast Neoplasms with a site in Egypt, this one is the 27th largest by enrollment of the 183 interventional ones that give a count, is one of 31 that started in 2024, is one of 85 with no phase, and was the 180th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

58 of the 248 studies in Breast Neoplasms with a site in Egypt are open now. Recruiting first, the newest first:

53 more — sign in →

All 58 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 21 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 248 studies in Breast Neoplasms with a site in Egypt, or all of them as a file.
02

Study summary

This study compares two methods of local pain control in patients undergoing Modified Radical Mastectomy, a common surgery for breast cancer( tumor in the breast) treatment. It aims to determine which method, the Thoracic Interfascial Plane Block or the Erector Spinae Plane Block, provides better pain relief after surgery, reduces side effects,decrease the incidence of persistent pain,improve quality of life and increases patient satisfaction.

Why This Study Is Important:

Breast cancer surgery can cause significant pain, and managing this pain is important for a quick recovery. Currently, pain is often managed with opioids, which can cause side effects like nausea and drowsiness. investigators want to find a method that controls pain effectively with fewer side effects, helping patients recover faster and feel better.

Who Can Take Part:

Women aged 21 and older who are scheduled for a Modified Radical Mastectomy at Ain Shams University hospitals can participate in this study.

What Will Happen During the Study:

Participants will be randomly assigned to receive either the Thoracic Interfascial Plane Block or the Erector Spinae Plane Block before surgery.

Pain levels will be measured using a numerical pain score from 1 to 10. Researchers will track the amount of pain medication needed, the time it takes to feel pain relief, and any side effects.

Other factors such as time to start walking again, and overall satisfaction with pain control will also be recorded.long term outcomes such as Persistent pain, Brief Pain Inventory interference, DN4-interview score, analgesic use and quality of life at 3 and 6 months.

What investigators hope to Learn:

Investigators hope to find out which nerve block provides better pain relief after surgery. By comparing TIPB and ESPB, with the aim to identify the method that:

Requires less additional pain medication Has fewer side effects Improves sleep quality and overall recovery Increases patient satisfaction

Significance:

This study could lead to better pain management strategies for breast cancer surgery, reducing the need for opioids and enhancing patient recovery and comfort, and improving long term satisfaction and quality of life.

Participation:

Participants will be monitored closely during and after the procedure to ensure their safety and well-being. The results of this study could help improve pain management for future patients undergoing similar surgeries.

Read the detailed description

This study is a randomized, double-blinded clinical trial comparing the efficacy of two ultrasound-guided nerve blocks for postoperative pain management in patients undergoing Modified Radical Mastectomy (MRM). The two techniques under investigation are the Thoracic Interfascial Plane Block (TIPB) and the Erector Spinae Plane Block (ESPB). Both nerve blocks are administered to provide targeted pain relief by numbing specific nerves involved in the surgical area.

Methodology:

Participants will be randomly assigned to one of two groups to receive either TIPB or ESPB. The randomization will ensure unbiased distribution of participants across both groups. The nerve blocks will be administered preoperatively under ultrasound guidance to ensure accurate placement and effectiveness.

Assessments and Measurements:

Pain levels will be assessed using the Visual Analog Scale (VAS) at multiple time points postoperatively, including at rest and during movement. The primary outcome measure is the total amount of rescue pain medication required within the first 48 hours after surgery. Secondary outcomes include the time to first rescue analgesic, intraoperative fentanyl consumption, hemodynamic parameters, sleep quality, time to first ambulation, VAS scores for pain and nausea, and overall patient satisfaction. Persistent pain, Brief Pain Inventory interference, DN4-interview score, analgesic use and quality of life will be assessed by blinded interview at 3 and 6 months

Safety and Monitoring:

Participants will be monitored for adverse events, including complications related to the nerve block techniques. Hemodynamic parameters, such as blood pressure and heart rate, will be closely observed during the perioperative period to ensure patient safety.

Significance:

The findings from this study aim to identify a short and long term superior pain management strategy that minimizes opioid consumption, reduces side effects, and enhances recovery and patient satisfaction following MRM. If successful, the results could inform clinical practice and improve postoperative care for breast cancer patients.

This study is conducted at Ain Shams University hospitals and adheres to ethical guidelines to ensure the safety and well-being of all participants.

03

Conditions studied

  • Postoperative Pain Following Modified Radical Mastectomy for Breast Cancer

Keywords

  • breast cancer
  • Modified Radical Mastectomy
  • Mastectomy
  • postoperative pain
  • Erector Spinae Plane Block
  • Thoracic Interfascial Plane Block
04

Who can participate

The criteria were revised on the registry on Oct 16, 2026. See what changed

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients older than 21 years old
  • (ASA) physical status II.

Exclusion criteria

Exclusion Criteria:

  • Known allergy to one of the study medications.
  • Skin infections at the site of the needle puncture.
  • Significant organ dysfunction (hepatic, renal, or cardiac dysfunction), coagulopathy or recent anticoagulant use, epilepsy.
  • Patients diagnosed with obstructive sleep apnoea, pulmonary compromise .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    Thoracic Interfascial Plane Block

    the Thoracic Interfascial Plane Block, which includes Pecto-Intercostal Fascial Plane Block and Serratus Intercostal Fascial Plane Block, is a peripheral nerve block that targets the intercostal nerve branches scattered throughout the chest and axilla

    Procedure: Thoracic Interfascial Plane Block

  • Active comparator
    Erector Spinae Plane Block

    Erector Spinae Plane Block (ESPB) is an anesthesia technique for providing effective analgesia during and after breast and abdominal surgery

    Procedure: Erector Spinae Plane Block

Interventions

  • ProcedureThoracic Interfascial Plane Block

    The Thoracic Interfascial Plane Block (TIPB) is a regional anesthesia technique used to manage postoperative pain, particularly in thoracic and breast surgeries. This block involves the injection of a local anesthetic into the fascial plane between the thoracic muscles, targeting the nerves that supply the chest wall and upper abdominal area. It includes Pecto-Intercostal Fascial Plane Block (PIFB) and Serratus Intercostal Fascial Plane Block (SIFB).

    Also known as: Thoracic Nerve Block, TIPB

  • ProcedureErector Spinae Plane Block

    The Erector Spinae Plane Block (ESPB) is a regional anesthesia technique used to manage pain, particularly in thoracic and abdominal surgeries. This block involves the injection of a local anesthetic into the plane between the erector spinae muscle and the transverse processes of the vertebrae.

    Also known as: ESPB

06

What researchers measure

Primary outcomes

  1. Total amount of rescue pain medication required within the first 48 hours after surgery

    Researchers will report the total amount of analgesia used in the first 48 hours after surgery

    Time frame: 48 hours

Secondary outcomes

  1. Time to first rescue analgesia'

    The time at which the first analgesia is adminstered after surgery

    Time frame: 48 hours

  2. Total intraoperative fentanyl consumption

    The total intraoperative consumption of fentanyl

    Time frame: Total intraoperative time of surgery

  3. Time for the first ambulation

    The time at which the patient will be first be able to ambulate from bed.

    Time frame: 48 hours

  4. VAS score for pain

    The postoperative pain using The Visual Analogue Scale (VAS) from 0 to 10, with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be).

    Time frame: 48 hours

  5. VAS score for nausea

    nausea during the postoperative period using Visual Analogue Scale (VAS) with two endpoints representing 0 ('no nausea') and 10 ('nausea as bad as it could be')

    Time frame: 48 hours

  6. Patient Satisfaction score

    (five-point Likert scale) where (1 = extremely dissatisfied to 5 = extremely satisfied) to measure postoperative patient satisfaction.

    Time frame: 48 hours

  7. presence of persistent pain

    pain in the operated breast, chest wall, axilla or ipsilateral arm that had been present since surgery and was not explained by local recurrence, infection or another identifiable cause on a 0-10 numerical rating scale

    Time frame: 3 months and 6 months

  8. Pain interference

    The seven interference items of the Brief Pain Inventory (general activity, mood, walking ability, normal work, relations with other people, sleep and enjoyment of life; each scored 0-10) were recorded, and the interference score was calculated as their mean

    Time frame: 3 months and 6 months

  9. Neuropathic symptoms

    Douleur Neuropathique 4 questionnaire (DN4-interview; range 0-7), a score of 3 or more indicated neuropathic pain

    Time frame: 3 and 6 months

  10. Analgesic use and pain-clinic attendance

    Patients were asked which medicines they were taking for surgical-site pain and at what daily dose and number of visits to pain-management clinic which then confirmed by hospital registry ,clinic and pharmacy records

    Time frame: 3 and 6 months

  11. Patient Global Impression of Change

    recorded on a seven-point scale from 1 (very much improved) to 7 (very much worse); scores of 1 or 2 were considered a clinically important improvement.

    Time frame: 3 and 6 months

  12. Health-related quality of life

    EORTC QLQ-C30 and its breast cancer module (QLQ-BR23) validated Arabic versions

    Time frame: 3 and 6 months

07

Study locations

1 site
  • Ainshams University Hospitals
    Cairo, Abbasiya 1181, Egypt
08

References and documents

Publications

  • Kaur U, Shamshery C, Agarwal A, Prakash N, Valiveru RC, Mishra P. Evaluation of postoperative pain in patients undergoing modified radical mastectomy with pectoralis or serratus-intercostal fascial plane blocks. Korean J Anesthesiol. 2020 Oct;73(5):425-433. doi: 10.4097/kja.20159. Epub 2020 Sep 24. PubMed 32987492 ↗
  • Hong B, Yoon SH, Youn AM, Kim BJ, Song S, Yoon Y. Thoracic interfascial nerve block for breast surgery in a pregnant woman: a case report. Korean J Anesthesiol. 2017 Apr;70(2):209-212. doi: 10.4097/kjae.2017.70.2.209. Epub 2017 Jan 12. PubMed 28367293 ↗
  • Zhang H, Miao Y, Qu Z. Refining a great idea: the consolidation of PECS I, PECS II and serratus blocks into a single thoracic fascial plane block, the SAP block-a concern on the muscle pain. Reg Anesth Pain Med. 2020 Jun;45(6):480. doi: 10.1136/rapm-2019-101042. Epub 2019 Oct 25. No abstract available. PubMed 31653798 ↗
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. PubMed 2748771 ↗
  • Boogaerts JG, Vanacker E, Seidel L, Albert A, Bardiau FM. Assessment of postoperative nausea using a visual analogue scale. Acta Anaesthesiol Scand. 2000 Apr;44(4):470-4. doi: 10.1034/j.1399-6576.2000.440420.x. PubMed 10757584 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Dec 2025, 13 months.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's 13 months is below that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Mar 2025 → Dec 2025 and completion Mar 2025 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2024
First posted
Aug 12, 2024
StartActual
Nov 1, 2024
Primary completionActual
Dec 1, 2025was Mar 2025
CompletionActual
Jun 20, 2026was Mar 2025
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 16, 2026
Primary completion
Mar 1, 2025→Dec 1, 2025 (actual)
Oct 16, 2026
Study completion
Mar 15, 2025→Jun 20, 2026 (actual)
Oct 16, 2026
Enrollment
50 (estimated)→200 (actual)
Oct 16, 2026
Eligibility
1 exclusion criterion edited
What changed in the criteria
Exclusion criteria
  • EditedKnown allergy to one of the study\'s medications.
Oct 16, 2026
Secondary outcomes
6 added, 1 removed
What changed in the outcomes
  • Addedpresence of persistent painTime frame: 3 months and 6 months
  • AddedPain interferenceTime frame: 3 months and 6 months
  • AddedNeuropathic symptomsTime frame: 3 and 6 months
  • AddedAnalgesic use and pain-clinic attendanceTime frame: 3 and 6 months
  • AddedPatient Global Impression of ChangeTime frame: 3 and 6 months
  • AddedHealth-related quality of lifeTime frame: 3 and 6 months
  • RemovedSleep qualityTime frame: 48 hours
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Recruiting→Completed
    Primary completion Mar 1, 2025→Dec 1, 2025 (now actual)
    Study completion Mar 15, 2025→Jun 20, 2026 (now actual)
    Enrollment 50 (estimated)→200 (actual)
    Eligibility 1 exclusion criterion edited
    What changed in the criteria
    Exclusion criteria
    • EditedKnown allergy to one of the study\'s medications.
    Secondary outcomes 6 added, 1 removed
    What changed in the outcomes
    • Addedpresence of persistent painTime frame: 3 months and 6 months
    • AddedPain interferenceTime frame: 3 months and 6 months
    • AddedNeuropathic symptomsTime frame: 3 and 6 months
    • AddedAnalgesic use and pain-clinic attendanceTime frame: 3 and 6 months
    • AddedPatient Global Impression of ChangeTime frame: 3 and 6 months
    • AddedHealth-related quality of lifeTime frame: 3 and 6 months
    • RemovedSleep qualityTime frame: 48 hours
    + 5 other changes: verification date, description, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06548646
Lead sponsor
Safie ramez tewfeik abd el moneim
Responsible party
Safie ramez tewfeik abd el moneim (Dr, Ain Shams University) — Sponsor-investigator
First posted
Aug 12, 2024
Start date
Nov 1, 2024
Primary completion
Dec 1, 2025
Completion
Jun 20, 2026
Last update
Oct 16, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion